Publishing Date: October 2012
Digital pathology includes scanning systems enabled in part by virtual microscopy, which is the practice of converting glass slides into digital slides that can be viewed, managed, and analyzed using an integrated system. This includes hardware as well as software systems enabling image management and workflow. Systems for research purpose also include RUO, CE-IVD and FDA-cleared 510(k) image analysis. It is a key driver to getting the right slide to the right pathologist (Telepathology) and enables diagnostic collaboration between specialists and researchers and the promise of workflow enhancement and efficiency.
These systems are useful for preclinical hisopathological studies by CROs and pharmaceutical companies, clinical diagnosis (this may not include image interpretation), pathological slides in clinical research. Within this space, cancer & toxicological pathology is of specific importance.
This report investigates the current digital pathology market, technological advancements, activities, trends observed in the market, explore potential opportunities for companies involved in this space, integrate stakeholder perception and quantify these findings into future market projections and geographic analysis.